People of color have been vastly underrepresented in U.S.-based vaccine trials for the last decade, according to a new study released Friday by researchers at Fred Hutchinson Cancer Research Center, Harvard, Emory and other institutions.The study, which examined data from 230 vaccine trials with nearly 220,000 participants, found that White people made up the majority, or 78%, of participants in trials conducted between June 2011